User:Mr. Ibrahem/Sumatriptan
Clinical data | |
---|---|
Trade names | Imitrex, Imigran, others |
AHFS/Drugs.com | Monograph |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth, subcutaneous injection, nasal spray, transdermal electrophoresis |
Drug class | Triptan[1] |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 15% (by mouth) / 96% (sc) |
Protein binding | 14–21% |
Metabolism | MAO |
Elimination half-life | 2.5 hours |
Excretion | 60% urine; 40% feces |
Identifiers | |
| |
Chemical and physical data | |
Formula | C14H21N3O2S |
Molar mass | 295.40 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Sumatriptan, sold under the brand name Imitrex among others, is a medication used to treat migraine headaches and cluster headaches.[2] It is taken by mouth, in the nose, or by injection under the skin.[1] Effects generally occur within three hours.[1]
Common side effects include chest pressure, feeling tired, feeling of the world spinning, vomiting, and tingling.[1] Serious side effects may include serotonin syndrome, heart attacks, strokes, and seizures.[1] With excessive use medication overuse headaches may occur.[1] It is unclear if use in pregnancy or breastfeeding is safe.[4] How it works is not entirely clear.[1] It is in the triptan class of medications.[1]
Sumatriptan was patented in 1982 and approved for medical use in 1991.[5] It is available as a generic medication.[2] In the United Kingdom it costs the NHS about £1 per dose as of 2019.[2] In the United States the wholesale cost of this amount is about US$0.60.[6] In 2017, it was the 97th most commonly prescribed medication in the United States, with more than eight million prescriptions.[7][8] It is also available as the combination product sumatriptan/naproxen at a cost of US$50 per dose.[6]
References[edit]
- ^ a b c d e f g h i "Sumatriptan Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 3 March 2019.
- ^ a b c d British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 474. ISBN 9780857113382.
- ^ a b c d "WHOCC - ATC/DDD Index". www.whocc.no. Retrieved 6 September 2020.
- ^ "Sumatriptan Use During Pregnancy". Drugs.com. Retrieved 3 March 2019.
- ^ Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 531. ISBN 9783527607495.
- ^ a b "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
- ^ "The Top 300 of 2020". ClinCalc. Retrieved 11 April 2020.
- ^ "Sumatriptan - Drug Usage Statistics". ClinCalc. Retrieved 11 April 2020.